Medicinova Inc financial data

Symbol
MNOV on Nasdaq
Industry
Pharmaceutical Preparations
Location
4275 Executive Square, Suite 300, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.73K % -10.2%
Debt-to-equity 5.54 % +3.55%
Return On Equity -17.6 % -23.5%
Return On Assets -16.6 % -23.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares 0%
Common Stock, Shares, Outstanding 49M shares 0%
Entity Public Float 109M USD -6.9%
Common Stock, Value, Issued 49K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD
Research and Development Expense 6.6M USD +20%
General and Administrative Expense 5.04M USD -10.3%
Operating Income (Loss) -12M USD -12.6%
Net Income (Loss) Attributable to Parent -10.3M USD -8.2%
Earnings Per Share, Basic -0.21 USD/shares -5%
Earnings Per Share, Diluted -0.21 USD/shares -5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.3M USD -17.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Assets, Current 43.3M USD -18.4%
Property, Plant and Equipment, Net 30.8K USD -39.9%
Operating Lease, Right-of-Use Asset 404K USD -34.6%
Goodwill 9.6M USD 0%
Other Assets, Noncurrent 19K USD -73.3%
Assets 58.1M USD -14.7%
Accounts Payable, Current 708K USD -3.89%
Employee-related Liabilities, Current 824K USD -10.4%
Liabilities, Current 2.6M USD -7.31%
Deferred Income Tax Liabilities, Net 202K USD 0%
Operating Lease, Liability, Noncurrent 255K USD -45%
Other Liabilities, Noncurrent 255K USD -45%
Liabilities 3.05M USD -11.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -124K USD -0.04%
Retained Earnings (Accumulated Deficit) -424M USD -2.49%
Stockholders' Equity Attributable to Parent 55.1M USD -14.9%
Liabilities and Equity 58.1M USD -14.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.87M USD -21.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -111%
Deferred Tax Assets, Valuation Allowance 83.4M USD +1.22%
Deferred Tax Assets, Gross 84.7M USD +1.19%
Operating Lease, Liability 457K USD -31.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD -8.21%
Lessee, Operating Lease, Liability, to be Paid 510K USD -34.3%
Property, Plant and Equipment, Gross 489K USD +2.35%
Operating Lease, Liability, Current 202K USD -1.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 206K USD -9.31%
Lessee, Operating Lease, Liability, to be Paid, Year One 227K USD -13.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 53.2K USD -50.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3K USD -91.6%
Deferred Tax Assets, Operating Loss Carryforwards 70M USD -0.23%
Unrecognized Tax Benefits 1.59M USD +77.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.3K USD -91.6%
Operating Lease, Payments 264K USD +2.21%
Depreciation, Depletion and Amortization 5.35K USD +30.3%
Share-based Payment Arrangement, Expense 690K USD -35.9%